AU5836700A - Peptides for therapeutic use - Google Patents

Peptides for therapeutic use

Info

Publication number
AU5836700A
AU5836700A AU58367/00A AU5836700A AU5836700A AU 5836700 A AU5836700 A AU 5836700A AU 58367/00 A AU58367/00 A AU 58367/00A AU 5836700 A AU5836700 A AU 5836700A AU 5836700 A AU5836700 A AU 5836700A
Authority
AU
Australia
Prior art keywords
peptides
therapeutic use
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU58367/00A
Inventor
Patrick T. Prendergast
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IE20000303A external-priority patent/IE20000303A1/en
Application filed by Individual filed Critical Individual
Publication of AU5836700A publication Critical patent/AU5836700A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4721—Lipocortins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU58367/00A 1999-06-01 2000-06-01 Peptides for therapeutic use Abandoned AU5836700A (en)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US13722799P 1999-06-01 1999-06-01
US60137227 1999-06-01
IE20000170 2000-03-03
IE2000/0170 2000-03-03
IE20000303A IE20000303A1 (en) 2000-04-13 2000-04-13 Peptides for Therapeutic use
IE2000/0303 2000-04-13
IE20000386 2000-05-18
IE2000/0385 2000-05-18
IE2000/0386 2000-05-18
IE20000385 2000-05-18
PCT/IB2000/000895 WO2000072868A2 (en) 1999-06-01 2000-06-01 Peptides for therapeutic use

Publications (1)

Publication Number Publication Date
AU5836700A true AU5836700A (en) 2000-12-18

Family

ID=27517569

Family Applications (1)

Application Number Title Priority Date Filing Date
AU58367/00A Abandoned AU5836700A (en) 1999-06-01 2000-06-01 Peptides for therapeutic use

Country Status (2)

Country Link
AU (1) AU5836700A (en)
WO (1) WO2000072868A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060281681A1 (en) 1997-05-28 2006-12-14 Pilon Aprile L Methods and compositions for the reduction of neutrophil influx and for the treatment of bronchpulmonary dysplasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary disease
GB0014870D0 (en) * 2000-06-16 2000-08-09 King S College London Peptides
WO2009046853A1 (en) * 2007-09-11 2009-04-16 Mondobiotech Laboratories Ag Use of intermedin 47 peptide as a therapeutic agent
CA2710406A1 (en) * 2007-09-11 2009-04-09 Dorian Bevec Use of a peptide as a therapeutic agent
WO2009140269A2 (en) 2008-05-13 2009-11-19 Clarassance, Inc. Recombinant human cc10 and compositions thereof for use in the treatment of nasal rhinitis
PL2488205T3 (en) 2009-10-15 2018-01-31 Clarassance Inc Recombinant human cc10 protein for treatment of influenza
US9168285B2 (en) 2009-10-15 2015-10-27 Therabron Therapeutics, Inc. Recombinant human CC10 protein for treatment of influenza and ebola
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5266562A (en) * 1987-11-19 1993-11-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Anti-inflammatory agents
BE1006919A3 (en) * 1993-03-15 1995-01-24 Ley Marc Jozef Philemon De PHARMACEUTICAL COMPOSITION BASED ON CLARA cell protein CC10, AND THEIR USE AS MEDICINE AND diagnostic.
US20020160948A1 (en) * 1998-07-21 2002-10-31 Aprile Pilon Recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
EP1173195B1 (en) * 1999-04-21 2007-10-10 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES UTEROGLOBIN IN THE TREATMENT OF IgA MEDIATED AUTOIMMUNE DISORDERS

Also Published As

Publication number Publication date
WO2000072868A3 (en) 2001-12-06
WO2000072868A2 (en) 2000-12-07

Similar Documents

Publication Publication Date Title
AU5259100A (en) Medicament
AU7358700A (en) Dolastatin peptides
AU6894700A (en) Therapeutic polypeptides and methods for using same
GB0128994D0 (en) Peptides
AU2001259837A1 (en) Therapeutic pore-forming peptides
AU1608201A (en) Human zven proteins
AU2451500A (en) Therapeutic agents
AU3978700A (en) Medical use
AU5836700A (en) Peptides for therapeutic use
AU5973600A (en) Therapeutic agents
EP1147130A4 (en) Alpha-conotoxin peptides
AU1043601A (en) Medical use
AU4456800A (en) Human hac3
AU3774000A (en) Conformationally constrained peptides
GB0120713D0 (en) Peptides
AU6150200A (en) Therapeutic agents
AUPQ386899A0 (en) Peptide compounds
AU7420800A (en) Medical use
GB9911238D0 (en) Therapeutic use
AU5817400A (en) Therapeutic agents
AU3808800A (en) Compounds for use in therapy
AU7655700A (en) Medicament combinations
AU5449200A (en) Cytoskeleton-associated proteins
AU6302300A (en) Therapeutic agents
AU5817500A (en) Therapeutic agents

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase